JHS Svendgaard Laboratories responded to NSE regarding discrepancies in Q2 FY26 financial results submission.
Company filed revised Integrated Financial Results on April 29, 2026, correcting inaccurate EPS figures.
Rectification addressed incorrect Board Meeting end time in NEAPS system and financial data inaccuracies.
Requested NSE to consider revised submission as full compliance with regulatory requirements.